These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 27585904)

  • 1. Clinical Pharmacology Studies in Critically Ill Children.
    Thakkar N; Salerno S; Hornik CP; Gonzalez D
    Pharm Res; 2017 Jan; 34(1):7-24. PubMed ID: 27585904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Altered Drug Pharmacokinetics in Critically Ill Adults Receiving Extracorporeal Membrane Oxygenation.
    Ha MA; Sieg AC
    Pharmacotherapy; 2017 Feb; 37(2):221-235. PubMed ID: 27931091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The challenges of multiple organ dysfunction syndrome and extra-corporeal circuits for drug delivery in critically ill patients.
    Hites M; Dell'Anna AM; Scolletta S; Taccone FS
    Adv Drug Deliv Rev; 2014 Nov; 77():12-21. PubMed ID: 24842474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy during pediatric extracorporeal membrane oxygenation: a review.
    Himebauch AS; Kilbaugh TJ; Zuppa AF
    Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1133-42. PubMed ID: 27322360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics in critically ill patients.
    Varghese JM; Roberts JA; Lipman J
    Curr Opin Anaesthesiol; 2010 Aug; 23(4):472-8. PubMed ID: 20489605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.
    Hahn J; Choi JH; Chang MJ
    J Clin Pharm Ther; 2017 Dec; 42(6):661-671. PubMed ID: 28948652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic/pharmacodynamic considerations for the optimization of antimicrobial delivery in the critically ill.
    Tsai D; Lipman J; Roberts JA
    Curr Opin Crit Care; 2015 Oct; 21(5):412-20. PubMed ID: 26348420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug absorption, distribution, metabolism and excretion considerations in critically ill adults.
    Roberts DJ; Hall RI
    Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1067-84. PubMed ID: 23682923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered pharmacology in the Intensive Care Unit patient.
    Zagli G; Tarantini F; Bonizzoli M; Di Filippo A; Peris A; De Gaudio AR; Geppetti P
    Fundam Clin Pharmacol; 2008 Oct; 22(5):493-501. PubMed ID: 18684127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of continuous renal replacement therapy on drug therapy.
    Susla GM
    Clin Pharmacol Ther; 2009 Nov; 86(5):562-5. PubMed ID: 19727069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics in the critically ill patient.
    Park GR
    Xenobiotica; 1993 Nov; 23(11):1195-230. PubMed ID: 8310706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice.
    Johnson TN; Rostami-Hodjegan A
    Paediatr Anaesth; 2011 Mar; 21(3):291-301. PubMed ID: 20497354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of renal replacement therapy on pharmacokinetics in critically ill patients.
    Bugge JF
    Best Pract Res Clin Anaesthesiol; 2004 Mar; 18(1):175-87. PubMed ID: 14760881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of Commonly Used Antimicrobials in Critically Ill Adults During Extracorporeal Membrane Oxygenation: A Systematic Review.
    Duceppe MA; Kanji S; Do AT; Ruo N; Cavayas YA; Albert M; Robert-Halabi M; Zavalkoff S; Dupont P; Samoukovic G; Williamson DR
    Drugs; 2021 Jul; 81(11):1307-1329. PubMed ID: 34224115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From Multiple Organ Support Therapy to Extracorporeal Organ Support in Critically Ill Patients.
    Ronco C; Ricci Z; Husain-Syed F
    Blood Purif; 2019; 48(2):99-105. PubMed ID: 31030203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal Dosing in Critically Ill Patients on Extracorporeal Membrane Oxygenation.
    Lyster H; Shekar K; Watt K; Reed A; Roberts JA; Abdul-Aziz MH
    Clin Pharmacokinet; 2023 Jul; 62(7):931-942. PubMed ID: 37300631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of continuous renal replacement therapy and mortality in critically ill children*.
    Modem V; Thompson M; Gollhofer D; Dhar AV; Quigley R
    Crit Care Med; 2014 Apr; 42(4):943-53. PubMed ID: 24231758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using PK/PD to optimize antibiotic dosing for critically ill patients.
    Roberts JA
    Curr Pharm Biotechnol; 2011 Dec; 12(12):2070-9. PubMed ID: 21554211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic concepts revisited--basic and applied.
    Patel K; Kirkpatrick CM
    Curr Pharm Biotechnol; 2011 Dec; 12(12):1983-90. PubMed ID: 21554220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of recommendations for dosing of commonly prescribed medications in critically ill obese children.
    Ross EL; Heizer J; Mixon MA; Jorgensen J; Valdez CA; Czaja AS; Reiter PD
    Am J Health Syst Pharm; 2015 Apr; 72(7):542-56. PubMed ID: 25788508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.